Cargando…

Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis

Intraperitoneal metastasis is a challenging clinical scenario in epithelial ovarian cancer (EOC). As they are distinct from hematogenous metastasizing tumors, epithelial ovarian cancer cells primarily disseminate within the peritoneal cavity to form superficially invasive carcinomas. Unfavorable pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lin-Yu, Huang, Rui-Lan, Su, Po-Hsuan, Chu, Ling-Hui, Weng, Yu-Chun, Wang, Hui-Chen, Lai, Hung-Cheng, Wen, Kuo-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101898/ https://www.ncbi.nlm.nih.gov/pubmed/35563509 http://dx.doi.org/10.3390/ijms23095120

Ejemplares similares

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015)

BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer
por: Darmawi,, et al.
Publicado: (2022)

The GPD program at COMPASS
por: Sznadjer, Pawel
Publicado: (2014)

The GPD program at COMPASS
por: Sandacz, Andrzej
Publicado: (2015)

GPD prospects at COMPASS
por: Burtin, Etienne
Publicado: (2009)

The GPD program at COMPASS
por: Sandacz, A
Publicado: (2009)

The GPD program at COMPASS
por: Sandacz, A
Publicado: (2011)

GPD program at COMPASS
por: D'Hose, N
Publicado: (2010)

GPD measurements at COMPASS
por: Lin, P J
Publicado: (2020)

Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis
por: Chu, Ling-Hui, et al.
Publicado: (2022)

An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients
por: Chang, Ping-Ying, et al.
Publicado: (2017)

Proposal for GPD studies at COMPASS
por: Burtin, E
Publicado: (2010)

AprGPD: the apricot genomic and phenotypic database
por: Chen, Chen, et al.
Publicado: (2021)

GPD study programme of COMPASS at CERN
por: Kouznetsov, O
Publicado: (2016)

Feasibility studies for GPD's measurement at COMPASS
por: Marroncle, J
Publicado: (2004)

Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer
por: Liu, Zhaoxia, et al.
Publicado: (2016)

Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients
por: Chou, Jian-Liang, et al.
Publicado: (2015)

Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
por: Liu, Yunyun, et al.
Publicado: (2018)

GPD physics with polarized muon beams at COMPASS-II
por: Ferrero, Andrea
Publicado: (2012)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
por: Fan, Zhengyang, et al.
Publicado: (2023)

Three Genes Predict Prognosis in Microenvironment of Ovarian Cancer
por: Guo, Ya, et al.
Publicado: (2020)

IFN-γ in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosis
por: Zheng, Hui, et al.
Publicado: (2023)

Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma
por: Xu, Lu, et al.
Publicado: (2019)

"GPD (Generador de la planeacion didactica para docentes)"
por: Rodríguez Camarena, Patricia
Publicado: (2009)

Effect of overexpression of LPAAT and GPD1 on lipid synthesis and composition in green microalga Chlamydomonas reinhardtii
por: Wang, Chaogang, et al.
Publicado: (2017)

Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
por: Chao, Tai-Kuang, et al.
Publicado: (2017)

Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer
por: Shan, Yan-Shen, et al.
Publicado: (2017)

High LIN28A and PLK4 co-expression is associated with poor prognosis in epithelial ovarian cancer
por: He, Yao, et al.
Publicado: (2018)

Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer
por: Xie, Xiaohui, et al.
Publicado: (2017)

Good Practice Data Linkage (GPD): A Translation of the German Version †
por: March, Stefanie, et al.
Publicado: (2020)

Non-bioenergetic roles of mitochondrial GPD2 promote tumor progression
por: Oh, Sehyun, et al.
Publicado: (2023)

Prognostic and Predictive Utility of GPD1L in Human Hepatocellular Carcinoma
por: Leung, Philip K. H., et al.
Publicado: (2023)

LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer
por: Wang, Shunni, et al.
Publicado: (2020)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer
por: Huang, Bihui, et al.
Publicado: (2016)

Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis
por: Fan, Huihui, et al.
Publicado: (2020)

FBXL7 Upregulation Predicts a Poor Prognosis and Associates with a Possible Mechanism for Paclitaxel Resistance in Ovarian Cancer
por: Chiu, Hui-Wen, et al.
Publicado: (2018)

Epigenomics of Ovarian Cancer and Its Chemoprevention
por: Chen, Huaping, et al.
Publicado: (2011)

Exclusively produced $\rho^0$ asymmetries on the deuteron and future GPD measurements at COMPASS
por: Schill, C.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_koi70jog85p2vaq7obhp64p6n2